Visioneering Technologies, Inc. (VTI.AX)
AUD 0.05
(6.52%)
AUD 0.05
(6.52%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 312.15 Thousand AUD | -74.18% |
| 2022 | 1.2 Million USD | -55.89% |
| 2021 | 2.74 Million AUD | -3.14% |
| 2020 | 2.83 Million AUD | -1.15% |
| 2019 | 2.86 Million AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | -100.0% |
| 2016 | 24.87 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - USD | -100.0% |
| 2024 Q2 | - USD | 0.0% |
| 2023 Q4 | 193.67 Thousand USD | -5.68% |
| 2023 Q2 | 1.85 Million USD | 0.37% |
| 2023 FY | 312.15 Thousand AUD | -74.18% |
| 2023 Q1 | 1.84 Million USD | 52.8% |
| 2023 Q3 | 205.33 Thousand USD | -88.93% |
| 2022 Q2 | 3.99 Million USD | 8.39% |
| 2022 Q4 | 1.2 Million USD | -45.62% |
| 2022 FY | 1.2 Million USD | -55.89% |
| 2022 Q1 | 3.68 Million USD | 34.51% |
| 2022 Q3 | 2.22 Million USD | -44.36% |
| 2021 Q1 | 3.9 Million USD | 6.31% |
| 2021 FY | 2.74 Million AUD | -3.14% |
| 2021 Q4 | 2.74 Million AUD | -27.97% |
| 2021 Q3 | 3.8 Million USD | -3.82% |
| 2021 Q2 | 3.95 Million USD | 1.3% |
| 2020 Q4 | 3.67 Million AUD | -33.87% |
| 2020 FY | 2.83 Million AUD | -1.15% |
| 2020 Q1 | 6.62 Million USD | 131.5% |
| 2020 Q2 | 5.9 Million USD | -10.89% |
| 2020 Q3 | 5.55 Million USD | -5.92% |
| 2019 Q4 | 2.86 Million AUD | -32.51% |
| 2019 FY | 2.86 Million AUD | 0.0% |
| 2019 Q3 | 4.24 Million USD | 1077.06% |
| 2019 Q2 | 360.37 Thousand USD | 1.14% |
| 2019 Q1 | 356.32 Thousand USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 FY | - AUD | -100.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 FY | 24.87 Million AUD | 0.0% |
| 2016 Q4 | 24.96 Million USD | 6.07% |
| 2016 Q3 | 23.53 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 93.904% |
| Adherium Limited | 93.2 Thousand AUD | -234.913% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 95.421% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -268.674% |
| Anteris Technologies Ltd | 2.33 Million AUD | 86.619% |
| Control Bionics Limited | 961.73 Thousand AUD | 67.543% |
| CardieX Limited | 3.22 Million AUD | 90.329% |
| Compumedics Limited | 6.97 Million AUD | 95.526% |
| Cochlear Limited | 243.7 Million AUD | 99.872% |
| CleanSpace Holdings Limited | 3.44 Million AUD | 90.942% |
| Cyclopharm Limited | 4.22 Million AUD | 92.616% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | 89.237% |
| Nova Eye Medical Limited | 3.34 Million AUD | 90.679% |
| HeraMED Limited | 260.65 Thousand AUD | -19.758% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 98.012% |
| ImpediMed Limited | 1.14 Million AUD | 72.69% |
| InhaleRx Limited | 560.27 Thousand AUD | 44.285% |
| LBT Innovations Limited | 1.74 Million AUD | 82.091% |
| Micro-X Limited | 4.05 Million AUD | 92.302% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -341.697% |
| PolyNovo Limited | 15.38 Million AUD | 97.97% |
| Respiri Limited | 1.17 Million AUD | 73.469% |
| SomnoMed Limited | 1.01 Million AUD | 69.276% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 93.721% |
| Uscom Limited | 989.27 Thousand AUD | 68.446% |